Cargando…
Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively
Background. Identifying diagnostic and prognostic biomarkers that could be targeted in the therapy of pancreatic cancer is essential. Objective. Investigations were conducted with respect to plasma miRNA (miR-21, miR-210, miR-155, miR-196a, miR-20a, and miR-25) expression and clinicopathologic facto...
Autores principales: | Yu, Qi, Xu, Changqing, Yuan, Wei, Wang, Chengfeng, Zhao, Ping, Chen, Lianzhen, Ma, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390608/ https://www.ncbi.nlm.nih.gov/pubmed/28466015 http://dx.doi.org/10.1155/2017/6495867 |
Ejemplares similares
-
Corrigendum to “Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively”
por: Yu, Qi, et al.
Publicado: (2018) -
Diagnostic Value of Plasma miR-181b, miR-196a, and miR-210 Combination in Pancreatic Cancer
por: Liu, Gongpan, et al.
Publicado: (2020) -
Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAs
por: Ranjha, Raju, et al.
Publicado: (2017) -
Correction: Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAs
por: Ranjha, Raju, et al.
Publicado: (2017) -
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
por: Qiu, Shuwei, et al.
Publicado: (2013)